AGA
ALXN
Altrinsic Global Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-70,000
| Closed | -$10.7M | – | 84 |
|
2021
Q1 | $10.7M | Hold |
70,000
| – | – | 0.34% | 45 |
|
2020
Q4 | $10.9M | Hold |
70,000
| – | – | 0.37% | 42 |
|
2020
Q3 | $8.01M | Hold |
70,000
| – | – | 0.33% | 42 |
|
2020
Q2 | $7.86M | Sell |
70,000
-5,000
| -7% | -$561K | 0.34% | 39 |
|
2020
Q1 | $6.73M | Buy |
75,000
+10,000
| +15% | +$898K | 0.37% | 40 |
|
2019
Q4 | $7.03M | Hold |
65,000
| – | – | 0.3% | 40 |
|
2019
Q3 | $6.37M | Hold |
65,000
| – | – | 0.28% | 43 |
|
2019
Q2 | $8.51M | Hold |
65,000
| – | – | 0.39% | 41 |
|
2019
Q1 | $8.79M | Hold |
65,000
| – | – | 0.41% | 42 |
|
2018
Q4 | $6.33M | Buy |
65,000
+5,000
| +8% | +$487K | 0.3% | 44 |
|
2018
Q3 | $8.34M | Buy |
60,000
+10,000
| +20% | +$1.39M | 0.38% | 41 |
|
2018
Q2 | $6.21M | Hold |
50,000
| – | – | 0.25% | 44 |
|
2018
Q1 | $5.57M | Buy |
50,000
+5,000
| +11% | +$557K | 0.23% | 43 |
|
2017
Q4 | $5.38M | Buy |
45,000
+20,000
| +80% | +$2.39M | 0.21% | 46 |
|
2017
Q3 | $3.51M | Sell |
25,000
-5,000
| -17% | -$701K | 0.13% | 59 |
|
2017
Q2 | $3.65M | Buy |
+30,000
| New | +$3.65M | 0.13% | 62 |
|